ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
NeuBase Therapeutics Inc

NeuBase Therapeutics Inc (NBSE)

0.4172
0.00
(0.00%)
Closed April 16 4:00PM
0.00
0.00
(0.00%)

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.4172
Bid
0.41
Ask
0.447
Volume
-
0.00 Day's Range 0.00
0.39 52 Week Range 5.40
Market Cap
Previous Close
0.4172
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
245,336
Shares Outstanding
3,729,206
Dividend Yield
-
PE Ratio
-0.05
Earnings Per Share (EPS)
-9.06
Revenue
-
Net Profit
-33.78M

About NeuBase Therapeutics Inc

NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, M... NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
NeuBase Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NBSE. The last closing price for NeuBase Therapeutics was $0.42. Over the last year, NeuBase Therapeutics shares have traded in a share price range of $ 0.39 to $ 5.40.

NeuBase Therapeutics currently has 3,729,206 shares outstanding. The market capitalization of NeuBase Therapeutics is $1.57 million. NeuBase Therapeutics has a price to earnings ratio (PE ratio) of -0.05.

NBSE Latest News

NeuBase Therapeutics Announces Receipt of Notice from Nasdaq

PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”) today reported that it received a notice (the “Notice) on April 4, 2024 from...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00320.7729468599030.4140.46530.39450310.41501654CS
4-0.6128-59.49514563111.031.150.392261730.60581385CS
12-0.2052-32.9691516710.62241.150.392453360.76499137CS
26-0.3319-44.30650113470.74911.510.392931590.86201219CS
52-2.7828-86.96253.25.40.398596072.0179661CS
156-128.3828-99.6760869565128.81320.3941112915.81038429CS
260-89.5828-99.536444444490257.80.3933455249.19746759CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.4174
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.04
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.90
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.2801
(0.00%)
0
AACGATA Creativity Global
$ 0.86
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.4174
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.04
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.90
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.2801
(0.00%)
0
AACGATA Creativity Global
$ 0.86
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.4174
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.04
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.90
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.2801
(0.00%)
0
AACGATA Creativity Global
$ 0.86
(0.00%)
0

NBSE Discussion

View Posts
willlbone willlbone 3 weeks ago
Plan of Dissolution...
👍️0
glenn1919 glenn1919 2 months ago
NBSE....................https://stockcharts.com/h-sc/ui?s=NBSE&p=W&b=5&g=0&id=p86431144783
👍️0
81vette 81vette 2 months ago
https://finance.yahoo.com/news/symetryx-corporation-acquires-20-stock-140000300.html
👍️0
81vette 81vette 2 months ago
jan 2nd,headquarters moved to dallas
👍️0
81vette 81vette 2 months ago
last news,nov.> https://www.globenewswire.com/news-release/2023/11/27/2786231/0/en/Psychemedics-Corporation-Appoints-Daniella-Mehalik-as-VP-Finance.html
👍️0
81vette 81vette 2 months ago
ohhh,this was a t s p,private pick from .67(over 100k followers) they usually are flippable for couple days or until his next pic starts running lol
👍️0
81vette 81vette 2 months ago
next res. sma200@ 1.34,blue sky above that,only old highs res. 1.51,3.16,4.44
👍️0
81vette 81vette 2 months ago
(NASDAQ: NBSE) shares surged 14.5% to $0.86 in pre-market trading. Neubase Therapeutics, on Feb. 22, said board determined for company to dissolve, liquidate and distribute to stockholders its available assets.
👍️0
81vette 81vette 2 months ago
had to load .81 for giggles
👍️0
81vette 81vette 2 months ago
shares to short,from 250k to 30k today,8k,if ZERO BORROW might run up
👍️0
Mojocash Mojocash 4 months ago
On watch!
👍️0
subslover subslover 4 months ago
holding yesterdays gains is a bullish signal IMHO
👍️0
gail gail 4 months ago
i have said, all along, that shorting should be illegal. allows for all kinds of manipulation.
👍️0
dinogreeves dinogreeves 4 months ago
Strategic initiatives is the name of the game, once merger is announced $5.00 is written all over it. No chasing, you chase the stock will get shorted back.
🕳️ 1 🪦 1 ⚰️ 1
gail gail 4 months ago
ended at 1.15 eod a/h.
👍️0
subslover subslover 4 months ago
Oh ok lol. Yea I agree :)
👍️0
J2003 J2003 4 months ago
HOD!!!
👍️0
subslover subslover 4 months ago
HOS?
👍️0
J2003 J2003 4 months ago
HOS close today would be awesome!
👍️0
gail gail 4 months ago
mr. trip is here too!,,,
👍️0
Triple nickle Triple nickle 4 months ago
Hope so it’s been slow
👍️0
subslover subslover 4 months ago
Look at this gail. === As of November 06, 2023, 3,729,206 shares of the common stock, par value $0.0001, of the registrant were outstanding.
👍️0
J2003 J2003 4 months ago
$2 after market close???
👍️0
gail gail 4 months ago
lets do this!
👍️0
subslover subslover 4 months ago
YES!!!!!!!!!!!!!!!!!!!!!!!
👍️0
gail gail 4 months ago
yup, i sure am!
👍️0
gail gail 4 months ago
yup, i sure am!
👍️0
subslover subslover 4 months ago
Hey Gail. Are you in this one? I took some $1.05's
👍️0
gail gail 4 months ago
hi subs!
👍️0
gail gail 4 months ago
here we gooooo, weeeee!!!!
👍️ 1
subslover subslover 4 months ago
Looks excellent dino!
👍️0
dinogreeves dinogreeves 4 months ago
It was inevitable.
🕳️ 1 🪦 1 ⚰️ 1
gail gail 4 months ago
nice buys coming in now.
👍️ 1 🖕 1 😁 1
gail gail 4 months ago
he dino, quiet board here. it …….

….

appears i was in this some time back but i hopped back in today, so, hi…. to you.
👍️0
dinogreeves dinogreeves 5 months ago
NBSE could hit big numbers today.
🕳️ 1 🖕 1 🤡 2 🤥 1
Gooddolphin Gooddolphin 5 months ago
Crazy trading going on today... hmmmmm
👍️0
gail gail 7 months ago
strong late night buying, lets do this!
👍️0
StockItOut StockItOut 7 months ago
Yet beginning three days later Symetryx sold all its shares of NBSE.

It seems Symetryx and the Neubase Board were unable to find or see eye to eye on a suitable merger candidate. Or something else that promoted a large active investor to sell its entire position.

Symetryx exits stake in NeuBase Therapeutics, shares fall
Sep. 19, 2023 2:03 PM ET
NeuBase Therapeutics, Inc. (NBSE)
By: Deepa Sarvaiya, SA News Editor

NeuBase Therapeutics (NASDAQ:NBSE) falls 14% after disclosing that Symetryx has sold its entire position in the biopharmaceutical company.
Symetryx sold 203,337 shares in the price range of $1.19-$1.44. Symetryx has sold 680,081 shares in the last 10 days.
According to the form 4 [Sept. 14th, 2023], Symetryx now beneficially owns no shares in the company.
As per the recent filing on Sept. 06, Symetryx acquired 20% stake in NeuBase.
https://seekingalpha.com/filing/7872032?hasComeFromMpArticle=false


Is today's higher action a bounce, or a facilitated bounce, or something real?

.
👍️0
levi levi 7 months ago
Hopefully. And the overall market is curling. I work all the time so I can’t keep up with it :(
👍️0
gail gail 7 months ago
looks like the investors meeting went well i guess.
👍️0
gail gail 7 months ago
yup, lots of buys hitting now.
👍️0
levi levi 7 months ago
Here it goes
👍️0
gail gail 7 months ago
nice buy hits this morning.
👍️0
gail gail 7 months ago
im assuming something slipped out thus the move today.
👍️0
levi levi 7 months ago
Sweet!! :) ty
👍️0
gail gail 7 months ago
they were saying, over on stock twits, that there is a shareholder meeting tomorrow and news of some sort is rumored. thats all i know.
👍️0
levi levi 7 months ago
Never know when news hits. Could run like vistagen . Fingers crossed.
👍️0
levi levi 7 months ago
I'm not selling. This is a good one to be stuck in imo .
👍️ 1
gail gail 7 months ago
and here we gooooo!! weee!! bring it on!!!
👍️0
gail gail 7 months ago
it may pop here soon.
👍️0

Your Recent History

Delayed Upgrade Clock